• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响多发性硬化症患者注射治疗依从性的因素及维持依从性的策略。

Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis.

出版信息

J Neurosci Nurs. 2010 Oct;42(5 Suppl):S10-8. doi: 10.1097/jnn.0b013e3181ee122b.

DOI:10.1097/jnn.0b013e3181ee122b
PMID:21049829
Abstract

A key aspect of the management of care for patients with multiple sclerosis (MS) is identifying which patients are struggling with adherence. Disease-modifying therapies for the treatment of MS are primarily preventative, with modest efficacy, and they can possibly cause significant side effects. These factors can lead patients to stop taking their medication because they continue to experience symptoms or relapses of the disease, and/or they have painful injection-site reactions on most parts of their bodies. However, striving for 100% adherence to the prescribed treatment regimen remains the goal and is the surest way to reap all the benefits associated with immunomodulatory therapy. Building trust, promoting injection self-efficacy, and educating patients about proper injection techniques to prevent injection-site reactions have the greatest impact on patient adherence. Factors including family involvement, financial stability and support, hope, and faith can also have a positive impact on adherence. Identifying patients who may be struggling with depression, which is easily treatable but often not well addressed, and providing access to mental health services are important. Although many strides have been made with regard to MS patient care, outlining strategies that can maintain or encourage adherence can provide practitioners with tools to facilitate their patients' health and well-being.

摘要

管理多发性硬化症 (MS) 患者护理的一个关键方面是确定哪些患者在坚持治疗方面存在困难。用于治疗 MS 的疾病修正疗法主要是预防性的,疗效有限,并且可能会引起明显的副作用。这些因素可能导致患者停止服用药物,因为他们仍在经历疾病的症状或复发,和/或他们在身体的大部分部位出现疼痛的注射部位反应。然而,努力达到 100%的依从性仍是目标,也是获得与免疫调节治疗相关的所有益处的最可靠方法。建立信任、提高注射自我效能感、教育患者正确的注射技术以预防注射部位反应,对提高患者的依从性有最大的影响。包括家庭参与、财务稳定和支持、希望和信仰在内的因素也可能对坚持治疗产生积极影响。确定可能正在与抑郁作斗争的患者,抑郁很容易治疗,但往往没有得到很好的解决,并提供获得心理健康服务的机会,这一点很重要。尽管在 MS 患者护理方面已经取得了许多进展,但制定可以维持或鼓励坚持治疗的策略,可以为从业者提供工具,促进患者的健康和福祉。

相似文献

1
Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis.影响多发性硬化症患者注射治疗依从性的因素及维持依从性的策略。
J Neurosci Nurs. 2010 Oct;42(5 Suppl):S10-8. doi: 10.1097/jnn.0b013e3181ee122b.
2
Enhancing adherence through education.通过教育提高依从性。
J Neurosci Nurs. 2010 Oct;42(5 Suppl):S19-29. doi: 10.1097/jnn.0b013e3181ef82b6.
3
Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data.可注射的疾病修正治疗对复发缓解型多发性硬化症:依从性数据的回顾。
J Neurosci Nurs. 2010 Oct;42(5 Suppl):S5-9. doi: 10.1097/jnn.0b013e3181ee1240.
4
Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis.改善干扰素在多发性硬化症治疗中耐受性的管理策略。
Can J Neurosci Nurs. 2008;30(4):18-25.
5
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.美国多发性硬化症患者对注射治疗的偏好:一项离散选择实验。
Patient. 2016 Apr;9(2):171-80. doi: 10.1007/s40271-015-0136-x.
6
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?满足提高多发性硬化症治疗依从性的需求:给药技术能否增强患者的积极性?
Expert Opin Drug Deliv. 2009 Sep;6(9):995-1002. doi: 10.1517/17425240903134769.
7
Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis.影响多发性硬化症患者对疾病修正治疗依从性的因素
J Neurosci Nurs. 2018 Oct;50(5):291-297. doi: 10.1097/JNN.0000000000000395.
8
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.优化治疗启动:一项关于芬戈莫德治疗的患者教育计划对知识、自我效能和患者满意度的影响。
Mult Scler Relat Disord. 2015 Sep;4(5):444-450. doi: 10.1016/j.msard.2015.06.010. Epub 2015 Jun 19.
9
[The nurse's role in multiple sclerosis treatment adherence].[护士在多发性硬化症治疗依从性方面的作用]
Soins. 2006 Oct(709):24-9.
10
A Multiple Sclerosis (MS) Center Injection Training Program.一个多发性硬化症(MS)中心注射培训项目。
Axone. 1997 Dec;19(2):29-33.

引用本文的文献

1
Patients' Engagement in Early Detection of COVID-19 Symptoms: An Observational Study in the Very Early Peak of the Pandemic in Italy in 2020.患者参与 COVID-19 症状的早期发现:2020 年意大利大流行初期的观察性研究。
Int J Environ Res Public Health. 2022 Mar 5;19(5):3058. doi: 10.3390/ijerph19053058.
2
Adherence to Therapy, Physical and Mental Quality of Life in Patients with Multiple Sclerosis.多发性硬化症患者的治疗依从性、身体和心理健康状况
J Pers Med. 2021 Jul 16;11(7):672. doi: 10.3390/jpm11070672.
3
Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland - a qualitative study.
瑞士基于药房的患者支持计划中接受芬戈莫德治疗的患者的满意度和体验 - 一项定性研究。
BMC Health Serv Res. 2020 May 14;20(1):425. doi: 10.1186/s12913-020-05278-3.
4
Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.新发复发型多发性硬化症患者决策辅助工具的开发与可用性测试
BMC Neurol. 2019 Jul 20;19(1):173. doi: 10.1186/s12883-019-1382-7.
5
Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study).使用电子注射装置皮下注射干扰素β-1a治疗的依从性:一项前瞻性开放标签的斯堪的纳维亚非干预性研究(ScanSmart研究)。
Patient Prefer Adherence. 2018 Apr 19;12:569-575. doi: 10.2147/PPA.S154417. eCollection 2018.
6
Adherence to Disease-Modifying Therapies for Multiple Sclerosis.多发性硬化症的疾病修正疗法的依从性。
J Manag Care Spec Pharm. 2016 Dec;22(12):1394-1401. doi: 10.18553/jmcp.2016.22.12.1394.
7
Multiple sclerosis in men: management considerations.男性多发性硬化症:管理考量
J Neurol. 2016 Jul;263(7):1263-73. doi: 10.1007/s00415-015-8005-z. Epub 2016 Jan 2.
8
The care continuum in acromegaly: how patients, nurses, and physicians can collaborate for successful treatment experiences.肢端肥大症的护理连续统一体:患者、护士和医生如何合作以获得成功的治疗体验。
Patient Prefer Adherence. 2015 Jul 30;9:1093-9. doi: 10.2147/PPA.S84887. eCollection 2015.
9
Self-efficacy as a longitudinal predictor of perceived cognitive impairment in individuals with multiple sclerosis.自我效能作为多发性硬化症患者认知功能障碍感知的纵向预测指标。
Arch Phys Med Rehabil. 2015 May;96(5):913-9. doi: 10.1016/j.apmr.2015.01.008. Epub 2015 Jan 15.
10
Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis.在一个多发性硬化症患者的国际样本中,与抑郁风险相关的生活方式因素、人口统计学特征和药物治疗
BMC Psychiatry. 2014 Dec 3;14:327. doi: 10.1186/s12888-014-0327-3.